Safety in an Evolving Psychedelic Landscape: Knowledge and Use of Psilocybin Safety Strategies, Resources, and Support in a Naturalistic Oregon Sample
Christina Chwyl, Kim Hoffman, Jason B. Luoma, Alissa Bazinet, Kellie Pertl, Philip Todd Korthuis, Adrianne R Wilson-Poe
Psychedelics October 1, 2026 DOI: 10.1016/j.psyche.2026.100042 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 31 |
| Population | Oregon residents who plan to use or have used psilocybin |
| Topics | Psilocybin |
| Key findings | Participants reported safety practices around source, dose, mindset, and setting but had knowledge gaps such as limited familiarity with substance testing kits. Most obtained information online and through personal networks, few were aware of state-regulated services, and many faced barriers to discussing psilocybin with healthcare providers, including perceived lack of provider knowledge, legal concerns, and fear of stigma. |
Abstract
Background: Real-world psilocybin use outpaces evidence-based guidance and accessible professional support; understanding psilocybin safety strategy and resource utilization is important for informing education and dissemination initiatives.
Methods: This qualitative study explored the perspectives of Oregon residents ( N = 31) who plan to/have used psilocybin, employing thematic analysis of one-on-one interviews to examine how individuals find, evaluate, and utilize information, safety strategies, and support services. Data collection occurred July–August, 2024.
Results: Within Theme 1 ( Foundations for Safer/Beneficial Use ) participants shared several foundational safety strategies, such as attending to source/dose, and mindset and setting, though exhibited several knowledge gaps, such as of substance testing kits. Theme 2 ( Education/Accessing Information ) found that participants primarily obtained information online and through personal networks, and desired consistent, trustworthy information. Theme 3 ( Use of Supports/Services ) indicated that several participants relied on peer support or trip sitters; few were aware of community supports or state-regulated services. Participants viewed unregulated guides as more accessible, with trustworthiness, reputation, and rapport prioritized over formal credentials. Theme 4 ( Interfacing with Healthcare Providers ) revealed participants often desired provider support, but encountered barriers (lack of provider knowledge, legal concerns, fear of stigma).
Conclusions: This is the first qualitative evidence on psilocybin safety strategies within the era of Oregon’s state-regulated access. Results revealed several novel insights, including potentially low state-regulated service awareness, emphasis on both communal and individual safety and barriers to open communication with healthcare providers. Improved resource dissemination (testing kits, trustworthy educational sources) and healthcare provider training around psilocybin are needed.
Comparable studies
Other qualitative studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression enrolled in an open-label trial of psilocybin | 2017 | Qualitative study | n = 20 |
| Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Adults aged 22 to 69 with clinically elevated anxiety associated with a cancer diagnosis | 2017 | Qualitative study | n = 13 |
| Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts Participants who completed a psilocybin-facilitated smoking cessation pilot study | 2018 | Qualitative follow-up study using semi-structured interviews and thematic analysis | n = 12 |
| Response of cluster headache to psilocybin and LSD Cluster headache patients who used psilocybin or LSD | 2006 | Qualitative study | n = 53 |
| Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress Adult participants with clinically elevated anxiety associated with a cancer diagnosis | 2017 | Qualitative study using interpretative phenomenological analysis | n = 13 |
Citations in the library
Cites 30
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Journal of Psychopharmacology November 18, 2016
- Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy 2021
- Extended difficulties following the use of psychedelic drugs: A mixed methods study PLoS One October 24, 2023
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Research May 1, 2024
and 25 more in the library